Amphiregulin-dependant deacetylation of Ku70 promotes BAX inhibition and resistance to gefitinib in non small cell lung cancer

被引：0
|
作者：
Busser, B. [1 ]
Niang, C. [1 ]
Coll, J. L. [1 ]
Favrot, M. [1 ]
Hurbin, A. [1 ]
机构：
[1] CHU Grenoble, Inst Albert Bonniot, INSERM, Dept Biol Integree Cancerol,U578, Grenoble, France
来源：
BULLETIN DU CANCER | 2008年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [41] Interaction of FLNA and ANXA2 promotes gefitinib resistance by activating the Wnt pathway in non-small-cell lung cancer
    Cheng, Lifang
    Tong, Qin
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2021, 476 (10) : 3563 - 3575
  • [42] Interaction of FLNA and ANXA2 promotes gefitinib resistance by activating the Wnt pathway in non-small-cell lung cancer
    Lifang Cheng
    Qin Tong
    Molecular and Cellular Biochemistry, 2021, 476 : 3563 - 3575
  • [43] Gefitinib/osimertinibDevelopment of resistance in small cell lung cancer: case report
    Reactions Weekly, 2019, 1744 (1) : 139 - 139
  • [44] Ku protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and γ radiation
    Ayene, IS
    Ford, LP
    Koch, CJ
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (04) : 529 - 536
  • [45] Gefitinib-Resistance Is Related to BIM Expression in Non-Small Cell Lung Cancer Cell Lines
    Li, Heyan
    Zhou, Songwen
    Li, Xuefei
    Wang, Daoyuan
    Wang, Yongsheng
    Zhou, Caicun
    Schmid-Bindert, Gerald
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2013, 28 (02) : 115 - 123
  • [46] Resistance to KRAS inhibition in advanced non-small cell lung cancer
    Sreter, Katherina Bernadette
    Catarata, Maria Joana
    von Laffert, Maximilian
    Frille, Armin
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [47] Review of the Treatment of Non-Small Cell Lung Cancer with Gefitinib
    Araki, Takuya
    Yashima, Hideaki
    Shimizu, Kimihiro
    Aomori, Tohru
    Hashita, Tadahiro
    Kaira, Kyoichi
    Nakamura, Tomonori
    Yamamoto, Koujirou
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [48] Gefitinib in the treatment of advanced non-small-cell lung cancer
    Reck, Martin
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 401 - 412
  • [49] Gefitinib for refractory advanced non-small-cell lung cancer
    Moriguchi, H
    Kim, TY
    Sato, C
    LANCET, 2006, 367 (9507): : 299 - 300
  • [50] Gefitinib plus clocetaxel in non-small-cell lung cancer
    Zalcman, Gerard
    Bergot, Emmanuel
    LANCET, 2009, 373 (9663): : 541 - 541
12345